Chemotherapy for advanced epithelial ovarian carcinoma

descriptionPublicationkeyboard_double_arrow_right Article 01 Aug 2002 English Publisher:Elsevier BVJournal:Best Practice & Research Clinical Obstetrics & Gynaecology, volume 16, pages 553-571 (issn: 1521-6934,

Copyright policy )

Authors: Nelson Gustavo Neder, Kalil; William Patrick, McGuire;

doi: 10.1053/beog.2002.0307

pmid: 12413934

Chemotherapy for advanced epithelial ovarian carcinoma

- Summary
- Subjects
- Metrics

Abstract

Advanced epithelial ovarian cancer (AOC) is the most common clinical presentation of ovarian cancer. Virtually all patients will require some form of chemotherapy with curative or palliative intent. Prognostic factors, first- and second-line therapy, as well as experimental approaches for AOC are reviewed.

Keywords

Ovarian Neoplasms, Chemotherapy, Adjuvant, Recurrence, Antineoplastic Combined Chemotherapy Protocols, Humans, Antineoplastic Agents, Female, Prognosis, Neoadjuvant Therapy

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	17
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%